Bourne Partners Adds Helen Stevenson as Executive Advisor

CHARLOTTE, N.C., Sept. 10 /CNW/ -- Bourne Partners is pleased to announce that Ms. Helen Stevenson, former Assistant Deputy Minister and Executive Officer, Ontario Public Drug Programs, has joined the firm as an Executive Advisor. In her five years in the Ontario Government, she led two sets of major reforms related to brand and generic drug pricing, and pharmacy reimbursement. Ms. Stevenson was also responsible for creating a new enterprise to manage all activities dealing with the publicly funded prescription drug programs, focused on reining in health care expenditures while at the same time providing access to new drugs for Ontarians.

Banks Bourne, Senior Managing Director, said: "As the chief executive officer, Helen was instrumental in reforming the Ontario Government's $4 billion provincial drug system and we are pleased to have her wealth of knowledge on the team. Helen will be working with us in an advisory role in new investments in Canada and the United States in the healthcare sector. She will also help us advance our Canadian portfolio company, Theramed Corporation; the company's lead product is for the reduction of surgical site infections - Collatamp G."

About Bourne Partners

Headquartered in Charlotte, North Carolina, Bourne Partners is a healthcare-focused merchant banking firm that provides advisory services and capital to companies throughout the world. The firm specializes in domestic and cross border advisory assignments with primary concentration in healthcare. Advisory areas of focus include corporate partnering (joint venture/licensing), mergers and acquisitions, and financing services. The firm's principals have completed healthcare transactions in 17 different countries aggregating over $2.5 billion in value. For additional information, visit www.bourne-partners.com.

For further information: CONTACT Jeremy Johnson, [phone], [e-mail]. Web Site: http://www.bourne-partners.com